Skip to content Skip to sidebar Skip to footer

Medicinal cannabis trial opens a new window for cancer sufferers

An Australian first medicinal cannabis trial has offered new treatment pathways for advanced cancer…

An Australian first medicinal cannabis trial has offered new treatment pathways for advanced cancer patients. 

Mater researchers observed the efficacy in cannabidiol (CBD) oil to provide symptom relief in more than 150 participants, who they say showed vast improvement in their overall wellbeing. 

Kevin Jocumsen, 66, said his mental health had eased within weeks of taking part in the trial.

“I have a whole new outlook on life,” he told Nursing Review.

“I honestly don't believe I'd be alive today if they had just kept on popping me with pills.”

First diagnosed with prostate cancer in 2011, the Queensland father of four was placed on strong pain medication after it began to spread up into his spine. 

He grew easily irritable and foggy, and said he was experiencing anxiety and depression on a weekly basis. 

“During this period, all through that, my mental health was sort of gone and down, doom and gloom a little bit, and anxiety was not too bad. It was handleable.

“Then it started to get worse. I got really bad. And then they put me on drugs to try and help control that.

“I don't even really remember, probably about two months of that.”

After spiralling into a depression, Kevin’s family intervened and he sought the help of Professor Janet Hardy for palliative care treatment. 

His pain medication was tweaked and he began the first stages of the randomized study. Each day, he filled a form to monitor his nausea, appetite and mental health. 

Kevin said within seven days he felt his mental health improve enormously, which enabled him to better manage his chronic pain. 

“The pain was less, my attitude was better.

“Before I did the oil the pain, even with all the painkillers, was pretty much a constant three all the time, now it's usually a one.

“I don't know whether it helps the pain, but I know when you're in a better mental state, that helps.”

Kevin is the proud grandfather to ten grandchildren. Picture: Supplied.

Leeanne, Kevin’s wife of over 34 years, said she began to notice the changes within days. Kevin became more interactive with family members and his regular mood swings began to subside. 

“We were just spiraling around and around, the different medications they tried. Some of them were just dreadful.

“And then the pain lessened, and his attitude got better again. So it was just continuing, evolving. 

“Now we're just under 12 months later, being on the oil and seeing things stabilised and the levels being better, and the pain being better. We've been upgrading our van and are planning a trip to travel around Australia.”

Legalised in Australia in 2016, doctors in most states can prescribe medicinal cannabis to patients with specific medical conditions, including epilepsy, chronic pain and chemotherapy-related nausea. 

While there continues to be substantial public demand, studies report obstructions to access have prevented eligible patients from taking the legal route.

Kevin, a Bribie Island man, said he has spoken to people with ill family members who have fought ongoing battles with doctors and health departments to obtain a script. 

“Part of the problem they're having here is most GPs won't prescribe it.

“I just think there needs to be a lot more research in it.”

In recent years, public acceptance towards medicinal cannabis has grown.

Surveys suggest, however, that GPs tend to hold a more conservative view, with less than sixty per cent agreeing that cannabis should be available in prescription. 

Medicinal cannabis products are also not currently part of the Pharmaceutical Benefits Scheme (PBS), and there is only one cannabis-based product currently listed on the Australian Register of Therapeutic goods. 

While effects of CBD in improving chronic pain are understudied, experts hope the results of the trial will pave the way for the country’s first registered cannabis treatment for people with advanced cancer. 

“The first phase of the trial and preliminary data shows a promising improvement amongst patients in emotional well-being,” said Hardy, who is the Mater Director of Palliative and Supportive Care Professor.

“It will also play a role in educating the general public about the appropriate usage of these products while developing a wider understanding of non-conventional treatments,” she said.

Kevin said he will continue CBD treatment for the rest of his life, and is looking forward to the future, especially travelling around the country with his wife.

“I don't know when I'm going to go, but whenever the cancer turns, I'm positive about it because everything's so good in my life at the moment.”

The findings of the first phase of the Mater cannabis trial is expected to be published next month, with two more randomised trials set to take place within the coming years. 

Leave a comment